Phase Iii, Randomized, Open-Label Trofuse-010 Study of Sacituzumab Tirumotecan (Sac-Tmt) Alone and with Pembrolizumab Vs Treatment of Physician's Choice Chemotherapy (Tpc) in Patients with Hr+/Her2-Unresectable Locally Advanced or Metastatic Breast Cancer (Mbc)